{
    "clinical_study": {
        "@rank": "34990", 
        "arm_group": [
            {
                "arm_group_label": "Breast Cancer Cases Among Men with No Exposure to Finasteride", 
                "description": "The number of new cases of male breast cancer among men with no exposure to finasteride in the registries of Denmark, Finland, Sweden, and Norway."
            }, 
            {
                "arm_group_label": "Breast Cancer Cases Among Men with Exposure to Finasteride", 
                "description": "The number of new cases of male breast cancer among men exposed to finasteride in the registries of Denmark, Finland, Sweden, and Norway."
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to investigate the potential association between finasteride\n      (MK-0906) exposure and the development of breast cancer in men residing in Denmark, Sweden,\n      Finland, and Norway from data in national registries."
        }, 
        "brief_title": "An Observational Registry-Based Study of a Potential Link Between Finasteride (MK-0906) and Male Breast Cancer in 4 Nordic Countries (MK-0906-162/2003.021)", 
        "completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Male Breast Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Breast Neoplasms, Male"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Participant's study medical information available in population-based health and\n             medical registries, prescription registries, and mortality registries in Denmark,\n             Finland, Norway, or Sweden within the observation period of 1995 to 2009\n\n          -  Male with breast cancer with medical information in one of the 4 country-specific\n             registries in this study\n\n          -  Study participant's exposure to finasteride is available"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Population-based health and medical registries, prescription registries, and mortality\n        registries in Denmark, Finland, Norway, and Sweden"
            }
        }, 
        "enrollment": {
            "#text": "270284", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01703520", 
            "org_study_id": "0906-162", 
            "secondary_id": "2003.021"
        }, 
        "intervention": {
            "arm_group_label": "Breast Cancer Cases Among Men with Exposure to Finasteride", 
            "description": "Prescribed as per routine clinical practice in Denmark, Sweden, Finland, and Norway.", 
            "intervention_name": "Finasteride", 
            "intervention_type": "Drug", 
            "other_name": [
                "MK-0906", 
                "PROSCAR\u00ae", 
                "PROPECIA\u00ae"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Finasteride"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Males breast cancer", 
            "Finasteride", 
            "PROSCAR\u00ae", 
            "PROPECIA\u00ae"
        ], 
        "lastchanged_date": "May 20, 2014", 
        "number_of_groups": "2", 
        "official_title": "A Multinational, Observational Registry-Based Study of a Potential Link Between Finasteride and Male Breast Cancer in 4 Nordic Countries", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Person-Years of Exposure to Finasteride by Participant Age and Year", 
                "safety_issue": "No", 
                "time_frame": "Up to 14 years"
            }, 
            {
                "measure": "Incidence Rates of Male Breast Cancer by Exposure to Finasteride", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 14 years"
            }, 
            {
                "measure": "All-Cause Mortality Rates in Males with Breast Cancer by Exposure to Finasteride", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 14 years"
            }
        ], 
        "removed_countries": {
            "country": "Denmark"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01703520"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Merck Sharp & Dohme Corp.", 
        "sponsors": {
            "collaborator": {
                "agency": "Institute for Applied Economics and Health Research Aps", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2011", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "May 2014"
    }
}